The document discusses the use of Wolbachia bacteria in the shrimping industry to produce female shrimp through feminization and parthenogenesis, while also increasing resistance and stress tolerance. It contrasts this with bdellovibrio, a predatory bacterium that targets gram-negative bacteria but cannot be used as a biological control for human pathogens due to its inability to invade mammalian cells. The potential for bdellovibrio as a therapeutic agent against antibiotic-resistant infections is highlighted, along with ongoing research into its safety and efficacy in humans.